Increased expression of vascular endothelial growth factor in bone marrow of multiple myeloma patients

European Journal of Internal Medicine

Volumn 14, Issue 2, 2003, Pages 98-100

  Wróbel, Tomasz ^a   Mazur, Grzegorz ^a   Surowiak, Paweł ^a   Dziȩgiel, Piotr ^a   Usnarska Zubkiewicz, Lidia ^a   Kuliczkowski, Kazimierz ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Angiogenesis; Multiple myeloma; VEGF

Indexed keywords

PARAFFIN; VASCULOTROPIN;

ADULT; AGED; ARTICLE; BONE MARROW BIOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MULTIPLE MYELOMA; PROTEIN EXPRESSION;

EID: 0345352733     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0953-6205(03)00027-X     Document Type: Article

References (14)

1. Belgore F.M., Lip G., Bareford D., et al. Plasma levels of vascular endothelial growth factor (VEGF) in haematological cancers. Br J Haematol. 110:2000;496-497.
2. Dankbar B., Padro T., Leo R., et al. Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in mutiple myeloma. Blood. 95:2000;2630-2636.
3. Durie B.G.M., Salmon S.E. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment and survival. Cancer. 36:1975;842-854.
4. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1:1995;27-31.
5. Hussong J.W., Rodgers G.M., Shami P.J. Evidence of increased angiogenesis in patients with acute myeloid leukemia. Blood. 95:2000;309-313.
6. Hsu S.M., Raine L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem. 29:1981;577-582.
7. McMahon G. VEGF receptor signaling in tumor angiogenesis. Oncologist. 5:2000;3-10.
8. Perez-Atayde A.R., Sallan S.E., Tedrow U., et al. Spectrum of tumor angiogenesis in bone marrow of children with acute lymphoblastic leukemia. Am J Pathol. 150:1997;815-821.
9. Podar K., Tai Y., Davies F.E., et al. Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration. Blood. 98:2001;428-435.
10. Remmele W., Stenger H.E. Vorschlag zur einheitlichen definition eines immunreaktiven score (IRS) fuer den immunohistochemischen oestrogenrezeptor-nachweis (ER-ICA) im mammakarzinomgewebe. Pathologe. 8:1987;138-140.
11. Shi S.R., Key M.E., Kalra K.L. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem. 39:1991;741-746.
12. Singhal S., Mehta J., Desikan R., et al. Antitumor activity of thalidomide in refractory multiple myeloma. New Engl J Med. 341:1999;1565-1571.
13. Vacca A., Ribatti D., Presta M., et al. Bone marrow neovascularisation, plasma cell angiogenic potential, and matrix metalloproteinase - 2 secretion parallel progression of human multiple myeloma. Blood. 13:1999;469-472.
14. Vacca A., Ribatti D., Roncali L., et al. Bone marrow angiogenesis and progression in multiple myeloma. Br J Haematol. 87:1994;503-508.